|
1
|
Shi C, Kang L, Yao S, Ma Y, Li T, Liang Y, Cheng Z, Xu Y, Shi J, Xu X, Zhang C, Franklin DR, Heaton RK, Jin H, Yu X. What is the optimal neuropsychological test battery for schizophrenia in China? Schizophr Res 2019; 208:317-323. [PMID: 30718121 PMCID: PMC6544499 DOI: 10.1016/j.schres.2019.01.034] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2018] [Revised: 01/22/2019] [Accepted: 01/26/2019] [Indexed: 01/10/2023]
Abstract
BACKGROUND The MATRICS consensus cognitive battery (MCCB) has been widely used to evaluate cognitive deficits in schizophrenia (SCZ), however, no study has formally examined the validity of the MCCB in Chinese SCZ. This study compared Chinese SCZ patients with healthy Chinese controls on the MCCB and some additional neurocognitive tests to determine if the Chinese MCCB is an optimal battery to assess the cognitive deficits in Chinese SCZ patients. METHOD The study enrolled and examined 230 patients met DSM-IV criteria for SCZ and 656 healthy controls matched for gender, age and education. Besides the MCCB, we also included some additional neurocognitive tests that have been widely used in patients with schizophrenia. We selected MCCB and non-MCCB tests with large effect size, to assemble a new "optimal battery" and compared its performance with that of the standard MCCB. RESULTS Comparing the putative "optimal" battery with the original MCCB, more patients with SCZ were identified as cognitively impaired according to the criteria of GDS ≥ 0.50 for the optimal battery (166 vs 135, or 72.2% vs 58.7%). The rate of cognitive impairment according to MCCB GDS in patients with SCZ who were currently working, ever worked and never worked are 45.5%, 61.6% and 70.8% (p = 0.051), whereas the optimal battery GDS showed 56.4%, 74.8%, 91.7% (p = 0.003), respectively. CONCLUSIONS Our study needs validation with independent samples but suggests that the current "optimal" cognitive battery could be more sensitive than the widely used MCCB in detecting SCZ related cognitive impairment in China.
Collapse
Affiliation(s)
- Chuan Shi
- Peking University Sixth Hospital, Beijing, China,Peking University Institute of Mental Health, Beijing, China,NHC Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, China,The National Clinical Research Center for Mental Health Disorders (Peking University Sixth Hospital), Beijing, China
| | - Lan Kang
- Peking University Sixth Hospital, Beijing, China,Peking University Institute of Mental Health, Beijing, China,NHC Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, China,The National Clinical Research Center for Mental Health Disorders (Peking University Sixth Hospital), Beijing, China
| | - Shuqiao Yao
- The Medical Psychological Research Center, Second Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Yibin Ma
- Peking University Sixth Hospital, Beijing, China,Peking University Institute of Mental Health, Beijing, China,NHC Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, China,The National Clinical Research Center for Mental Health Disorders (Peking University Sixth Hospital), Beijing, China
| | - Tao Li
- Peking University Sixth Hospital, Beijing, China,Peking University Institute of Mental Health, Beijing, China,NHC Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, China,The National Clinical Research Center for Mental Health Disorders (Peking University Sixth Hospital), Beijing, China
| | - Ying Liang
- Peking University Sixth Hospital, Beijing, China,Peking University Institute of Mental Health, Beijing, China,NHC Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, China,The National Clinical Research Center for Mental Health Disorders (Peking University Sixth Hospital), Beijing, China
| | - Zhang Cheng
- Peking University Sixth Hospital, Beijing, China,Peking University Institute of Mental Health, Beijing, China,NHC Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, China,The National Clinical Research Center for Mental Health Disorders (Peking University Sixth Hospital), Beijing, China
| | - Yifeng Xu
- Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Jianguo Shi
- Xian Mental Health Center, New Qujiang District, Xian, Shanxi, China
| | - Xiufeng Xu
- Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
| | - Congpei Zhang
- The First Haerbin Psychiatric Hospital, Haerbin, Heilongjiang, China
| | - Donald R. Franklin
- Department of Psychiatry, University of California at San Diego, San Diego, CA, USA
| | - Robert K. Heaton
- Department of Psychiatry, University of California at San Diego, San Diego, CA, USA
| | - Hua Jin
- Department of Psychiatry, University of California at San Diego, San Diego, CA, USA.
| | - Xin Yu
- Peking University Sixth Hospital, Beijing, China; Peking University Institute of Mental Health, Beijing, China; NHC Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing, China; The National Clinical Research Center for Mental Health Disorders (Peking University Sixth Hospital), Beijing, China.
| |
Collapse
|